World-renowned experts in science and medicine at TGen Drug Development (TD2) are dedicated to providing our clients with comprehensive services that help move novel compounds as efficiently as possible through Phase I, II and III clinical trials.

TD2's biomarker - and patient-selection strategies give our clients' compounds - and patients - the greatest chance of success, even in the earliest stages of clinical development.

TD2's expertise in all aspects of clinical research includes clinical development plans, program analysis, medical writing and clinical trial management.  TD2 provides a full spectrum of contract research organization (CRO) capabilities in a cost-effective way by sourcing, managing and overseeing database development, data management, statistical analyses and monitoring functions by our trusted, world-class partners.

What makes TD2 unique is our comprehensive understanding of oncology clinical development, combined with our deep commitment to scientific discovery and innovation.  TD2 combines the support offered by a full-service clinical research organization (CRO) with the benefits of working with a small, specialized oncology-focused group on the forefront of cancer research.